Valuation IDEXX Laboratories, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-09-17 pm EDT			5-day change	1st Jan Change
512.27 ^USD	+0.17%		+3.29%	-7.71%

Sep. 04	Transcript : IDEXX Laboratories, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 11:30 AM
Aug. 15	Transcript : IDEXX Laboratories, Inc. - Analyst/Investor Day

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	22,400	42,639	55,833	33,786	46,098	42,090	-	-
Change	-	90.35%	30.94%	-39.49%	36.44%	-8.7%	-	-
Enterprise Value (EV) ¹	23,298	43,163	56,612	35,022	46,592	42,529	42,374	42,032
Change	-	85.27%	31.16%	-38.14%	33.04%	-8.72%	-0.36%	-0.81%
P/E ratio	53.4x	74.5x	76.6x	50.8x	55.2x	48.4x	41.8x	36.7x
PBR	127x	67.5x	82.6x	55.6x	31x	23.5x	17.8x	13x
PEG	-	2x	2.7x	-7.66x	2.2x	9.21x	2.6x	2.7x
Capitalization / Revenue	9.31x	15.8x	17.4x	10x	12.6x	10.7x	9.83x	8.99x
EV / Revenue	9.68x	15.9x	17.6x	10.4x	12.7x	10.8x	9.9x	8.97x
EV / EBITDA	36.4x	54.6x	54.6x	34.7x	38.4x	32.8x	28.9x	26.8x
EV / EBIT	42.1x	62.1x	60.7x	39x	42.5x	37.4x	32.3x	28.8x
EV / FCF	76.6x	79.8x	89x	88.9x	60.3x	49.8x	42.4x	38.8x
FCF Yield	1.31%	1.25%	1.12%	1.13%	1.66%	2.01%	2.36%	2.58%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	4.89	6.71	8.6	8.03	10.06	10.59	12.27	13.94
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	2,407	2,707	3,215	3,367	3,661	3,920	4,280	4,684
EBITDA ¹	640.9	790.5	1,037	1,011	1,212	1,295	1,464	1,568
EBIT ¹	552.8	694.5	932	898.8	1,097	1,136	1,313	1,458
Net income ¹	427.7	581.8	744.8	679.1	845	879.1	1,011	1,131
Net Debt ¹	897.3	524.6	779.2	1,236	493.9	439.5	284.5	-57.72
Reference price ²	261.13	499.87	658.46	407.96	555.05	512.27	512.27	512.27
Nbr of stocks (in thousands)	85,783	85,300	84,794	82,817	83,052	82,306	-	-
Announcement Date	1/31/20	2/2/21	2/2/22	2/6/23	2/5/24	-	-	-